Skip to main content
. 2013 Jun;32(6):334–341. doi: 10.5732/cjc.012.10093

Figure 2. Kaplan-Meier curve showing the overall survival (OS) of patients with unresectable pancreatic cancer who were treated with minimally invasive therapies.

Figure 2.

The 1-, 2-, and 3-year OS rates were 32.4%, 9.9%, and 6.6%, respectively.